Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Journal of Diabetes Science and Technology|October 16, 2012
Effect of insulin feedback on closed-loop glucose control: a crossover studyJessica L Ruiz, Jennifer L Sherr, Eda Cengiz, et al.
Diabetes Technology & Therapeutics|December 26, 2013
Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warmingEda Cengiz, Stuart A Weinzimer, Jennifer L Sherr, et al.
The Journal of Clinical Endocrinology and Metabolism|December 7, 2017
Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 DiabetesAlfonso Galderisi, Jennifer Sherr, Michelle VanName, et al.
Diabetes Technology & Therapeutics|October 26, 2017
Altered Patterns of Early Metabolic Decompensation in Type 1 Diabetes During Treatment with a SGLT2 Inhibitor: An Insulin Pump Suspension StudyNeha S Patel, Michelle A Van Name, Eda Cengiz, et al.
Diabetes Care|July 21, 2012
Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetesStuart A Weinzimer, Jennifer L Sherr, Eda Cengiz, et al.
Canadian Journal of Diabetes|August 15, 2020
Alcohol Use and Clinical Outcomes in Adults in the Type 1 Diabetes ExchangeSheila M Alessi, Nicole C Foster, Carla J Rash, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 10, 2011
A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitusEda Cengiz, Jennifer L Sherr, Ayca Erkin-Cakmak, et al.
Diabetes Care|June 13, 2013
Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetesJennifer L Sherr, Eda Cengiz, Cesar C Palerm, et al.
The Science of Diabetes Self-Management and Care|June 2, 2025
AGP Reports for Glucose and Insulin Devices Qualitative Study: What Patients and Clinicians WantDeborah M Mullen, Richard M Bergenstal, Mary Johnson, et al.
Diabetes Technology & Therapeutics|July 10, 2020
Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin StudyBruce W Bode, Eda Cengiz, R Paul Wadwa, et al.
Pageof 8